Archived news features

  • How accurate are rapid tests for diagnosing COVID‐19? What are rapid point‐of‐care tests for COVID‐19?Rapid point‐of‐care tests aim to confirm or rule out COVID‐19 infection in people with or without COVID‐19 symptoms. They:‐ are portable, so they can be used wherever the patient is (at the point of care);‐ are easy to perform, with a minimum...
    March 24 2021
  • The Cochrane Library releases an updated Special Collection on diagnosing tuberculosisWorld Tuberculosis Day is marked annually on 24 March, and commemorates the date in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis.This Special Collection, curated by Cochrane...
    March 23 2021
  • How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?Why is using Xpert tests to screen for pulmonary tuberculosis important?Tuberculosis is the leading cause of infectious disease‐related death and one of the top 10 causes of death...
    March 23 2021
  • Original version published on 30 September 2020.This is the second update of this review. The review authors included studies in people with suspected COVID-19 only, and excluded studies in people with confirmed COVID-19. The evidence is up to date to 30 September 2020. How accurate is chest imaging for diagnosing COVID‐19?Why is this...
    March 17 2021
  • During May 2021, we have published 2 new Cochrane reviews and one Cochrane review update in Issue 5, 2021 of the Cochrane Database of Systematic Reviews. New reviewsHaraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis...
    March 7 2021
  • One new COVID-19 review, one updated COVID-19 review, and one updated Cochrane review  are in Issue 2, 2021 of the Cochrane Database of Systematic Reviews.New COVID 19 ReviewSingh  B, Ryan  H, Kredo  T, Chaplin  M, Fletcher  T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19....
    March 3 2021
  • An updated systematic review from Cochrane Infectious Diseases Group  published today; 'Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease'.Can symptoms and medical examination accurately diagnose COVID-19?COVID-19 affects many organs of the body, so people with...
    February 23 2021
  • Why is improving the diagnosis of pulmonary tuberculosis important?Tuberculosis is one of the leading causes of death worldwide. While tuberculosis is largely curable when detected early and effectively treated, around 1.2 million people died of tuberculosis in 2019. Xpert MTB/RIF and Xpert Ultra (the newest version) are World Health Organization‐...
    February 23 2021
  • Hydroxychloroquine does not reduce deaths from COVID-19, and probably does not reduce the number of people needing mechanical ventilation, state the authors of a new Cochrane Review. In addition, they note that no new trials of hydroxychloroquine or chloroquine for treating COVID-19 should be started.Authors based in India, South Africa, and...
    February 12 2021
  • What are the benefits and risks of atovaquone‐proguanil for treating uncomplicated malaria caused by the Plasmodium falciparum parasite?What is the aim of this review?The most common, and most serious, type of malaria is caused by Plasmodium falciparum. In its mild (uncomplicated) form, the symptoms are fever, headaches, muscle pain, and...
    January 19 2021

Pages

Subscribe to Our news